FCUV vs IOSP

For growth investors, Innospec Inc.

(IOSP) is the stronger pick with -3. 7% revenue growth year-over-year, versus -9. 6% for Focus Universal Inc. (FCUV). Innospec Inc. (IOSP) offers the better valuation at 16. 4x trailing P/E (15. 5x forward), making it the more compelling value choice. Analysts rate Innospec Inc. (IOSP) a "Hold" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Innospec Inc.

(IOSP) delivered a total return of -18. 3%, compared to -99. 7% for Focus Universal Inc. (FCUV). Over 10 years, the gap is even starker: IOSP returned +84. 4% versus FCUV's -98. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Innospec Inc.

(IOSP) is the lower-risk stock at 0. 70β versus Focus Universal Inc. 's 1. 79β — meaning FCUV is approximately 157% more volatile than IOSP relative to the S&P 500. On balance sheet safety, Focus Universal Inc. (FCUV) carries a lower debt/equity ratio of 4% versus 7% for Innospec Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Innospec Inc.

(IOSP) is pulling ahead at -3. 7% versus -9. 6% for Focus Universal Inc. (FCUV). On earnings-per-share growth, the picture is similar: Innospec Inc. grew EPS 228. 9% year-over-year, compared to 38. 5% for Focus Universal Inc.. Over a 3-year CAGR, IOSP leads at -3. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Innospec Inc.

(IOSP) is the more profitable company, earning 6. 6% net margin versus -803. 8% for Focus Universal Inc. — meaning it keeps 6. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IOSP leads at 8. 8% versus -1557. 3% for FCUV. At the gross margin level — before operating expenses — IOSP leads at 27. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, IOSP (2.

2% yield) pays a dividend. FCUV does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Innospec Inc.

(IOSP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 70), 2. 2% yield). Focus Universal Inc. (FCUV) carries a higher beta of 1. 79 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (IOSP: +84. 4%, FCUV: -98. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (FCUV (Technology) and IOSP (Basic Materials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: FCUV is a small-cap quality compounder stock; IOSP is a small-cap deep-value stock. IOSP pays a dividend while FCUV does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.